Michael D. Kluger MD MPH
Hepatobiliary Surgery, Pancreas, Surgical Oncology (Other than Breast)
Professor, Surgery, New York University Grossman School of Medicine
Join to View Full Profile
577 First Avenue, 2nd FloorNew York, NY 10016
Phone+1 212-263-2630
Fax+1 929-455-9692
Dr. Kluger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Kluger is a seasoned general surgeon based in New York, NY, with subspecialties in hepatobiliary surgery, pancreas, and surgical oncology. He completed his medical education at New York University School of Medicine and surgical residency at New York Presbyterian Hospital (Columbia Campus). Dr. Kluger is currently a professor at NYU Langone Health and has held various academic positions, including associate and assistant professorships at prestigious institutions like Columbia University and Weill Cornell Medicine. His clinical expertise encompasses pancreatic cancer, liver cancer, gallbladder disease with a prolific publication record in high-impact journals. He has also led clinical trials in areas such as pancreatic disease. Dr. Kluger has been consistently recognized as a top doctor and received awards for his contributions to medical education and surgery.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Chief Residency, Surgery, 2008 - 2009- New York Presbyterian Hospital (Columbia Campus)Residency, Surgery, 2004 - 2008
New York University School of MedicineClass of 2004
Yale UniversityMPH, 1997 - 1999- Union CollegeBS, Biology & Psychology, 1992 - 1996
Certifications & Licensure
NJ State Medical License 2022 - 2027
NY State Medical License 2005 - 2027
CT State Medical License 2023 - 2025
American Board of Surgery Surgery
Awards, Honors, & Recognition
- Top Doctors Castle Connolly, 2018-2025
- Teaching & Mentor Award Department of Surgery, Columbia University, 2015, 2024
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2012-2017
Clinical Trials
- Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma Start of enrollment: 2017 Sep 22
- PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 1 citationsConsensus Guideline for the Management of Peritoneal Mesothelioma.Leanne M Brown, Sarah G Wilkins, Varun V Bansal, David G Su, Jorge Gomez-Mayorga
Annals of Surgical Oncology. 2026-06-01 - Proposal for an Objective and Concrete Definition for Determining Anatomic Resectability in Pancreatic Cancer: The Concept of the "Suitable Target".Alessio Marchetti, Jonathan Garnier, Giampaolo Perri, Brock D Hewitt, Greg D Sacks
Journal of the American College of Surgeons. 2026-05-01 - Development and Validation of a Parsimonious Risk Stratification Model for Pancreatic Cancer.Lucas A Mavromatis, Viktor Zlatanic, Emil Agarunov, Shenin A Sanoba, Michael D Kluger
JAMA Oncology. 2026-05-01
Journal Articles
- Dabigatran (Pradaxa) Is Safe for Extended Venous Thromboembolism Prophylaxis After Surgery for Pancreatic CancerJohn A Chabot, Michael D Kluger, Beth A Schrope, Journal of gastrointestinal surgery
- Access and use of health care: perceptions and experiences among people who use heroin and cocaineWeiss L, McCoy K, Kluger M, Finkelstein R, Addiction Research and Theory, 1/1/2004
Books/Book Chapters
Abstracts/Posters
- Recurrence of malignant peritoneal mesothelioma: Novel insights based on standardized second look procedures.Heller D, Kluger MD, Greene A, Leinwand J, Bates GE, Chabot JA, Taub RN, American Society of Clinical Oncology Annual Meeting, Chicago, IL, 1/1/2015
- Long-term outcomes of cytoreduction and HIPEC for malignant peritoneal mesothelioma.Bates GE, Kluger MD, Jin Z, Chabot JA, Leinwand J, Bressler T, Rae M, Taub RN, Borczuk AC, Hesdorffer M, American Society of Clinical Oncology Annual Meeting, Chicago, IL, 1/1/2015
- Irreversible electroporation is safe and feasible for the control and treatment of locally-advanced and borderline resectable pancreatic cancer: short-term results.Winner M, Epelboym I, Kluger MD, Chabot JA, 48th Annual Pancreas Club Meeting, Chicago, IL, 1/1/2014
Lectures
- Irreversible electroporation (Nanoknife®) for pancreatic cancer: a single institution series of 50 consecutive patients.Miami, FL - 1/1/2015
- CT peritonography of dwell intraperitoneal chemotherapy for peritoneal mesothelioma.Washington, DC - 1/1/2015
- Recurrent malignant peritoneal mesothelioma causing massive gastrointestinal bleeding: not all histologies are stable or equal.Clearwater Beach, FL - 1/1/2015
Press Mentions
Scientists Find Trigger That Sets off Metastasis in Pancreatic CancerJune 28th, 2022
Pleural and Peritoneal Mesothelioma Combination Can Be ManagedJanuary 9th, 2020- New Study Shows Improved Peritoneal Mesothelioma SurvivalOctober 31st, 2017
Professional Memberships
- Member
- Member
- Fellow
- Fellow
- Member
External Links
- Columbia Doctorshttp://www.columbiadoctors.org/prof/mkluger
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
